Larimar Therapeutics (LRMR) Gains from Investment Securities (2016 - 2020)
Historic Gains from Investment Securities for Larimar Therapeutics (LRMR) over the last 6 years, with Q3 2020 value amounting to $2.0 million.
- Larimar Therapeutics' Gains from Investment Securities fell 6180.74% to $2.0 million in Q3 2020 from the same period last year, while for Dec 2020 it was $789000.0, marking a year-over-year change of. This contributed to the annual value of $465000.0 for FY2024, which is 4113.92% down from last year.
- According to the latest figures from Q3 2020, Larimar Therapeutics' Gains from Investment Securities is $2.0 million, which was down 6180.74% from $720067.0 recorded in Q2 2020.
- Larimar Therapeutics' Gains from Investment Securities' 5-year high stood at $5.1 million during Q3 2019, with a 5-year trough of $448000.0 in Q1 2020.
- For the 5-year period, Larimar Therapeutics' Gains from Investment Securities averaged around $2.1 million, with its median value being $2.0 million (2019).
- As far as peak fluctuations go, Larimar Therapeutics' Gains from Investment Securities surged by 31357.14% in 2018, and later crashed by 7745.11% in 2020.
- Over the past 5 years, Larimar Therapeutics' Gains from Investment Securities (Quarter) stood at $1.5 million in 2016, then fell by 20.47% to $1.2 million in 2017, then surged by 313.57% to $5.0 million in 2018, then increased by 1.87% to $5.1 million in 2019, then plummeted by 61.81% to $2.0 million in 2020.
- Its last three reported values are $2.0 million in Q3 2020, $720067.0 for Q2 2020, and $448000.0 during Q1 2020.